Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....
Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....
Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....
Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....
Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....
Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....
Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....
According to recent reports, Johnson & Johnson is considering selling its Cerenovus stroke business for 1 billion dollars....
Johnson & Johnson, one of the world's largest pharmaceutical companies, has announced its acquisition of psychiatric drug developer Intra-Cellular. The deal, valued at $14....
Pharmaceutical giant AbbVie Inc. (ABBV) experienced a significant drop in stock prices today, following disappointing results from their latest schizophrenia drug trials....
Regeneron Pharmaceuticals Inc. (REGN) is a biopharmaceutical company known for its pioneering work in developing innovative therapies....
Vertex Pharmaceuticals Incorporated (VRTX), a leading biotechnology company, has reported its strong financial results for the fourth quarter and full year of 2024....
GSK PLC, a leading pharmaceutical company, has recently announced its acquisition of IDRx, a US-based biotech business, for a staggering amount of 1 billion dollars....